Overview

Safety and Efficacy Evaluation of DOTAREMĀ® in MRI of Central Nervous System (CNS) Lesions

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the safety (what are the side effects)and efficacy (how well does it work) of DotaremĀ® when used in taking images of the brain / spine. The results will be compared to the results of MRI taken without Dotarem.
Phase:
Phase 3
Details
Lead Sponsor:
Guerbet
Treatments:
Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate